RITTER PHARMACEUTICALS INC Business Finance Contracts & Agreements

102 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Securities Purchase Agreement
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Placement Agent Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Pre-Funded Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Placement Agency Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Placement Agency Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Placement Agency Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Promissory Note, dated July 12, 2024, issued by Qualigen Therapeutics, Inc. to Marizyme, Inc
Note Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Senior Note dated June 8, 2024
Note Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Securities Purchase Agreement dated July 5, 2024
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2024
Common Stock Purchase Warrant dated April 12, 2024, issued by us to Yi Hua Chen
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
8% Convertible Debenture dated April 12, 2024, issued by us to Yi Hua Chen
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2024
Form of Common Stock Purchase Warrant to be issued by the Company to Alpha Capital Anstalt [Exhibit C to the Securities Purchase Agreement dated February 26, 2024]
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2024
Form of 8% Convertible Debenture to be issued by the Company to Alpha Capital Anstalt [Exhibit A to the Securities Purchase Agreement dated February 26, 2024]
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2024
Securities Purchase Agreement dated February 26, 2024 between the Company and Alpha Capital Anstalt
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2024
Amendment No. 1 with regard to Securities Purchase Agreement, dated December 5, 2023, between the Company and Alpha Capital Anstalt
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2023
Consent and Waiver, dated September 22, 2023, between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt
Waiver Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2023
Stock Purchase Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc., Chembio Diagnostics, Inc., Biosynex, S.A., and Qualigen, Inc
Stock Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2023
Registration Rights Agreement, dated December 22, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt
Registration Rights Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
8% Senior Convertible Debenture Due December 22, 2025
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2022
Securities Purchase Agreement, dated December 21, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2022
Common Stock Purchase Warrant for 2,500,000 shares in favor of Alpha Capital Anstalt, dated December 22, 2022
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Amendment No. 1 to the 2022 Employee Stock Purchase Plan of Qualigen Therapeutics, Inc
Stock Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Qualigen Therapeutics, Inc. 2022 Employee Stock Purchase Plan
Stock Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2022
Pre-Funded Common Stock Purchase Warrant issued by the Company in favor of Alpha Capital Anstalt, dated May 26, 2022
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Master Agreement for the Operational and Technological Funding of NanoSynex between Qualigen Therapeutics, Inc. and NanoSynex Ltd., dated May 26, 2022
Funding Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Share Purchase Agreement between the Company and Alpha Capital Anstalt dated April 29, 2022
Share Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2022
Series B Preferred Share Purchase Agreement between the Company and NanoSynex Ltd. dated April 29, 2022
Share Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Amended and Restated Common Stock Purchase Warrant to Christopher Nelson (300,000 shares)
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Amended and Restated Common Stock Purchase Warrant to GreenBlock Capital LLC (300,000 shares)
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Waiver and Amendment between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt, dated November 29, 2021
Waiver Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2021
Securities Purchase Agreement, dated November 29, 2021
Purchase Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2021
Prefunded Common Stock Purchase Warrant for 1,000,000 shares, dated December 18, 2020
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2020
Deferred Common Stock Purchase Warrant for 842,696 shares, dated December 18, 2020
Warrant Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2020